SCHEMBL6600744

SCHEMBL6600744

O=C(Nc1ccc(C(=O)N2CCCC(c3ccc4c(c3)OCO4)=N2)cc1)c1ccncc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.61
MAPT P10636 9/20 0.56
RAB9A P51151 6/20 0.56
NPC1 O15118 5/20 0.56
ALDH1A1 P00352 4/20 0.56
PKM P14618 2/20 0.56
HPGD P15428 1/20 0.56
RECQL P46063 1/20 0.56
CASP3 P42574 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SMN1; SMN2 Q16637 5/20 0.53
HSD17B10 Q99714 1/20 0.53
NAMPT P43490 3/20 0.52
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
PGR P06401 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145733 0.89 ALDH1A1 (0.56) AHRMAPTRAB9ANPC1ALDH1A1
SCHEMBL6602633 0.89 NPC1 (0.48) AHRMAPTRAB9ANPC1ALDH1A1
SCHEMBL6606418 0.88 MAPT (0.50) AHRMAPTRAB9ANPC1ALDH1A1
SCHEMBL6600684 0.87 NPC1 (0.63) AHRMAPTRAB9ANPC1ALDH1A1
SCHEMBL6603502 0.86 MAPT (0.56) MAPTRAB9ANPC1ALDH1A1PKM
SCHEMBL6602828 0.86 NPC1 (0.61) MAPTRAB9ANPC1ALDH1A1PKM
SCHEMBL6600335 0.86 MAPT (0.48) AHRMAPTRAB9ANPC1ALDH1A1
SCHEMBL6607585 0.85 MAPK1 (0.62) MAPTRAB9ANPC1ALDH1A1PKM
SCHEMBL6604801 0.85 ALDH1A1 (0.49) MAPTRAB9ANPC1ALDH1A1PKM
SCHEMBL6602833 0.84 AHR (0.50) AHRMAPTRAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed